Cirna Diagnostics

Cirna is an Oxford-based biotechnology company specializing in the development of circular RNA (circRNA) based diagnostics for early disease detection. Spun out from the University of Oxford in 2023, the company utilizes a proprietary platform to identify and quantify stable circRNA biomarkers in blood samples, addressing the limitations of traditional linear RNA and protein-based tests. Their primary focus is on oncology, aiming to provide non-invasive liquid biopsy tests for cancers that are currently difficult to detect in early stages. The technology integrates advanced sequencing and bioinformatics to translate complex RNA data into actionable clinical insights for precision medicine.